Title : Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach.

Pub. Date : 2020 Dec

PMID : 32920239






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The atomic structure of Mpro in complex with an alpha-ketoamide inhibitor (Lig13b) is available (PDB ID:6Y2G). alpha-ketoamide NEWENTRY Severe acute respiratory syndrome-related coronavirus